Attenua, Inc.
Menlo Park, CA · Founded 2015 · CIK 0001736945 · Software
AI conversational system with persistent memory that learns and evolves across multiple sessions
attenua.io →- Grants
- —
- No SBIR or STTR on record
- Sector median: 0
- Raised
- $15M
- 1 Form D · Apr 2018
- 101 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 2 granted · 7 pending
- Sector median: 0
Capital Timeline
Federal ↑Equity ↓20172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $15,203,154 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1592 | Edge AI Solutions Inc. | — | $130K |
| 1593 | Let's Fantasy Game, Inc. | — | $25K |
| 1594 | Cuby Technologies, Inc. | — | $23M |
| 1595 | Attenua, Inc. | — | $15M |
| 1596 | CKM Analytix, Inc. | — | $1.0M |
| 1597 | Treis Blockchain, LLC | — | $370K |
| 1598 | Golioth Inc | — | $7.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Dina Chaya MoghrabiDirector
- Rishi GuptaDirector
- Michael KittDirector · Executive Officer
- Jing LiangDirector
- Hugh RienhoffDirector
- Kurt von EmsterDirector
Patents
- Antitussive Compositions And Methodsapplication
- Antitussive Compositions And Methodsgranted
- Preparation And Therapeutic Applications Of (2S,3R)-N-2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2.2.2]OCT-3-YL)-3,5-DIFLUOROBENZAMIDEapplication
- Nicotinic Acetylcholine Receptor Sub-type Selective Amides Of Diazabicycloalkanesgranted
- (2S,3R)-N-(2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2.2.2]OCT-3-YL)BENZOFURAN-2-CARBOXAMIDE, Novel Salt Forms, And Methods Of Use Thereofapplication
- Antitussive Compositions And Methodsapplication
- Antitussive Compositions And Methodsapplication
- Antitussive Compositions And Methodsapplication
- Antitussive Compositions And Methodsapplication